Life sciences news
-
Aitia and UCB announce strategic drug discovery collaboration in Huntington's Disease
Thursday March 16th 2023
Read more
-
Celyad Oncology announces non-cash impairment
Wednesday March 15th 2023
Read more
-
Oxurion provides update on recruitment for KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema and announces Board changes
Tuesday March 14th 2023
Read more
-
Biotalys announces Chief Financial Officer succession plan
Tuesday March 14th 2023
Read more
-
New protein function could explain cause of neurological disease
Tuesday March 14th 2023
Read more
-
UCB’s Board of Directors appoints Jonathan Peacock as new Chair
Thursday March 9th 2023
Read more
-
Cancer Research UK signs multi-project collaboration with UCB to advance oncology antibody candidates
Thursday March 9th 2023
Read more
-
Mithra announces promising topline safety results from Donesta® Phase 3 Study in North America
Monday March 6th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
VIB spin-off Flamingo Therapeutics merges with Dynacure to create leading RNA therapeutics company in oncology
Thursday March 2nd 2023
Read more
-
Confo Therapeutics announces Global Licensing Agreement with Lilly for peripheral pain candidate, CFTX-1554
Thursday March 2nd 2023
Read more
-
Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test
Thursday March 2nd 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
